SAID MOSTAFAVI, M.D.,
Sleep Medicine (Internal Medicine) Physician in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
SAID MOSTAFAVI, M.D., reported a CMS MIPS final score of 12.9144/100 — below the 83.1 national average — and filed 519 Medicare Part D claims in 2023.
- 12.9144/100
- MIPS score · -70 vs avg
- 519
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
SAID MOSTAFAVI, M.D.,'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
13 2nd percentile higher than 2% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
SAID MOSTAFAVI, M.D., practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about SAID MOSTAFAVI, M.D.,?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Sleep Medicine (Internal Medicine) Physician compares to other specialties among California providers
Sleep Medicine (Internal Medicine) Physician share within California
Sleep Medicine (Internal Medicine) Physician is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
SAID MOSTAFAVI, M.D.,'s 2023 MIPS final score plotted against the Sleep Medicine (Internal Medicine) Physician national average
- MIPS Final Score
- 12.9144/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Sleep Medicine (Internal Medicine) Physician) — 12.9144/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Sleep Medicine (Internal Medicine) Physician US NPIs
12.9144/100 MIPS final score — 70.2 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Sleep Medicine (Internal Medicine) Physician. Quality dim: 0. Cost dim: 43.048.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
SAID MOSTAFAVI, M.D., appears in the CMS NPPES registry as a Sleep Medicine (Internal Medicine) Physician provider holding M.D., credentials at 2080 CENTURY PARK EAST, LOS ANGELES, CA, 90067, with a listed phone of (310) 551-1881. NPI 1639163744 was issued on 09/02/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MOSTAFAVI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 519 prescription claims written by this provider, covering 102 Medicare beneficiaries and totaling roughly $116K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 12.9144/100 for the 2023 performance year (Quality 0, Cost 43.048), compared with the national average of 83.1.
Sleep Medicine (Internal Medicine) Physician is a narrow specialty nationwide, with 857 enrolled providers across 52 states and an average of 1,310 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1639163744 |
|---|---|
| Specialty | Sleep Medicine (Internal Medicine) Physician |
| Credentials | M.D., |
| Gender | Male |
| NPI Issued | 09/02/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm SAID MOSTAFAVI, M.D.,'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SAID MOSTAFAVI, M.D.,. Source: openpaymentsdata.cms.gov.
Total received
$1.7K
Largest payer
W. L. Gore & Associates, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to SAID MOSTAFAVI, M.D.,. To verify SAID MOSTAFAVI, M.D.,'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 644
- Total Day Supply
- 17,555
- Generic Drug Cost
- $6K
- Antibiotic Claims
- 58
Patient Demographics
- Average Patient Age
- 77.0 years
- Avg HCC Risk Score
- 1.31
- Gender Split
- 51% female / 49% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What SAID MOSTAFAVI, M.D., prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trelegy Ellipta
Trelegy Ellipta
57 claims
- Combivent Respimat
Combivent Respimat
53 claims
- Montelukast Sodium
Montelukast Sodium
50 claims
- Azithromycin
Azithromycin
32 claims
- Famotidine
Famotidine
25 claims
- Lansoprazole
Lansoprazole
25 claims
- Breo Ellipta
Breo Ellipta
24 claims
- Gabapentin 20
Gabapentin
20 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 57 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 53 |
| Montelukast Sodium | 50 |
| Azithromycin | 32 |
| Famotidine | 25 |
| Lansoprazole | 25 |
| Breo Ellipta Fluticasone/Vilanterol | 24 |
| Gabapentin | 20 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 16 |
| Fluticasone Propionate | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Sleep Medicine (Internal Medicine) Physician Overview
How SAID MOSTAFAVI, M.D., fits within the Sleep Medicine (Internal Medicine) Physician landscape nationally.
SAID MOSTAFAVI, M.D.,'s 519 claims are below the specialty average of 1,310.
Nearby Sleep Medicine (Internal Medicine) Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as MOSTAFAVI.
Compare Sleep Medicine (Internal Medicine) Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is SAID MOSTAFAVI, M.D.,'s specialty? ▼
How much does SAID MOSTAFAVI, M.D., prescribe under Medicare Part D? ▼
What is SAID MOSTAFAVI, M.D.,'s Medicare quality score? ▼
Where is SAID MOSTAFAVI, M.D., located? ▼
What is SAID MOSTAFAVI, M.D.,'s NPI number? ▼
How many Sleep Medicine (Internal Medicine) Physician providers are there in the US? ▼
What drugs does SAID MOSTAFAVI, M.D., prescribe most often? ▼
Does SAID MOSTAFAVI, M.D., accept Medicare? ▼
How can I verify SAID MOSTAFAVI, M.D.,'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology